Gill-Pazaris L A, Brown A R, Nisonoff A
Ann Immunol (Paris). 1979 Mar-Apr;130(2):199-213.
Antiphenylarsonate (anti-Ar) hybridomas were prepared according to Milstein and Köhler with the cell line 45.6TG1.7 and A/J spleen. About 20% of initial wells with anti-Ar activity expressed the major A/J cross-reactive idiotype. Many wells contained anti-Ar antibodies whose binding to Ar-coated plates was strongly inhibited by antiidiotypic (anti-id) antibody but which did not compete effectively with labelled serum antibody for anti-id. Three such hybridoma products (HP) were cloned twice in agar; a 4th was cloned once. All were IgG1K. Each of the four HP, when specifically purified from a BGG-Ar-Sepharose and then radiolabelled, was strongly bound by anti-id. Pooled purified anti-Ar antibodies and anti-Ar antiserum from 9 of 10 mice competed with each HP for anti-id. The serum of the mouse which was non-inhibitory contained normal amounts of the major cross-reactive idiotype. These results demonstrate the presence of cross-reactive anti-Ar idiotypes other than the major idiotype in the A/J strain. Such idiotypes represent a small proportion of the anti-Ar population. Serological analysis of the four HP, which may reflect the serum antibody population, suggest that these "minor" idiotypes may be quite heterogeneous. An HP which did compete with the major cross-reactive idiotype for anti-id failed to compete with three of the four HP described above. This provides support for the concept that the "minor" idiotypes are serologically distinct from the major cross-reactive idiotype.
根据米尔斯坦和科勒的方法,用45.6TG1.7细胞系和A/J品系小鼠脾脏制备抗苯胂酸(anti-Ar)杂交瘤。约20%具有抗Ar活性的初始孔表达主要的A/J交叉反应独特型。许多孔含有抗Ar抗体,其与包被Ar的平板的结合被抗独特型(anti-id)抗体强烈抑制,但与标记的血清抗体竞争anti-id时效果不佳。三种这样的杂交瘤产物(HP)在琼脂中克隆了两次;第四种克隆了一次。所有产物均为IgG1K。从BGG-Ar-琼脂糖凝胶中特异性纯化并进行放射性标记后,这四种HP中的每一种都能与anti-id强烈结合。从10只小鼠中的9只获得的纯化抗Ar抗体和抗Ar抗血清与每种HP竞争anti-id。不具有抑制作用的小鼠血清中含有正常量的主要交叉反应独特型。这些结果表明,在A/J品系中存在除主要独特型之外的交叉反应抗Ar独特型。此类独特型在抗Ar群体中占比很小。对这四种HP的血清学分析(可能反映血清抗体群体)表明,这些“次要”独特型可能相当异质。一种能与主要交叉反应独特型竞争anti-id的HP,不能与上述四种HP中的三种竞争。这为“次要”独特型在血清学上与主要交叉反应独特型不同这一概念提供了支持。